A board of advisers matches you up with a company with the experience and technology to do the job. You pay them to do the job...and they report back whether they got the same results.This still seems like a potential conflict to me, as the for-hire companies doing the validation will still have far more incentive to corroborate your results (since you're paying for them) and very little upside to failing to reproduce the study, especially since, from the second link FAQ, "You only have to pay upon completion of the replication study by the provider,...". So if I disagree with the results of the reproducibility study on my work, I can lodge a complaint with the inititative and refuse to pay until my dispute has been resolved, while the company has already completed the work and would have to wait before seeing any money for it. It seems to me like this isn't really a suitable replacement for independent verification of results. Not to mention, 10% of the cost of the original study is not necessarily peanuts, especially for smaller labs that might not be swimming in extra research money.
Elizabeth Iorns, chief executive of Science Exchange — a commercial online portal that matches scientists with experimental service providers — noticed that a number of drug companies were employing researchers to validate published results. It prompted her to develop the Reproducibility Initiative, a mechanism to replicate research results, with a particular focus on preclinical biological studies.posted by euphorb at 3:15 PM on August 14, 2012 [4 favorites]
...
The Reproducibility Initiative will work through Science Exchange, which is based in Palo Alto, California.
How the heck is that supposed to work? The only way I can see it costing less to reproduce the result than to obtain the result in the first place, is if you just slavishly copy the experimental methods of the original lab, skipping the parts that turned out to be dead ends, and maybe borrow a bunch of their equipment too -- or anyway, duplicate it as exactly as possilbe so that the same experimental techniques and data analysis tools work.Yeah, I think that's the point.
Once you do that, it is hardly "independent" verification. The lab might as well just repeat its own experimentThey are verifying that the experiment has the results they say it does, the point is to avoid dishonestly (or erroneously) claiming results that don't exist. Re-running the experiment might help with the errors, but won't help with the dishonesty.
Any lab anywhere - we can call them Bounty Labs - is allowed to take any study published in certain journals and attempt to reproduce it at their own cost. If they cannot, an independent Verification Commission investigates - if it transpires that indeed it is not possible to duplicate the study, then the research lab that originated the study has to pay the Bounty Lab the cost of the attempt to reproduce plus a bounty of X dollarsThat just seems ridiculously complicated, and adds risk for no reason. For one thing, it makes costs impossible to calculate. If you're 95% sure your result is right, you can assume a 5% chance the result might not work. But you wouldn't be able to figure the cost that these 'bounty labs' might charge.
The scientific community assumes that the claims in a preclinical study can be taken at face value," Begley and Lee Ellis of MD Anderson Cancer Center wrote in Nature. It assumes, too, that "the main message of the paper can be relied on ... Unfortunately, this is not always the case."Neither of these two assertions is true. In fact, a great deal of scientific effort goes into proving that the previous findings are false. Falsification is at the basis of scientific theories and is the main stuff of scientific endeavor. Besides, who decided they were "landmark" studies, rather than ones that looked interesting because, if true, they could lead to big bucks for Amgen?
« Older Lowell "The Hammer" Stanley looks like your garden... | Kansas City rapper and budding... Newer »
This thread has been archived and is closed to new comments
That gives everyone a big incentive to make sure the same results are reproduced, but where's the incentive for finding results that differ from the original result? In the current system there's various reasons why an independent team of researchers would want to prove some incorrect published research wrong, but I don't see much of that translating to a company being paid by the people who most want the results to hold up.
posted by burnmp3s at 11:51 AM on August 14, 2012 [4 favorites]